Compare BMRA & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMRA | UCL |
|---|---|---|
| Founded | 1971 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 10.6M |
| IPO Year | 1995 | 2019 |
| Metric | BMRA | UCL |
|---|---|---|
| Price | $1.68 | $0.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.3K | ★ 251.4K |
| Earning Date | 10-15-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.81 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,453,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $15.99 |
| P/E Ratio | ★ N/A | $13.72 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.45 | $0.22 |
| 52 Week High | $3.09 | $2.63 |
| Indicator | BMRA | UCL |
|---|---|---|
| Relative Strength Index (RSI) | 32.36 | 26.30 |
| Support Level | $1.50 | $0.22 |
| Resistance Level | $1.71 | $0.44 |
| Average True Range (ATR) | 0.10 | 0.02 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 14.81 | 4.07 |
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America generating key revenue from North American Markets.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data-related products globally. Its uCloudlink cloud SIM platform is designed for shared mobile data connectivity services by allocating the SIM cards remotely and dynamically to users. Ucloudlink's core business is to provide mobile data connectivity services at competitive prices, which it delivers through a range of hardware products and service solutions to its business partners, retail, and enterprise customers. The main hardware terminals offered by the company include portable Wi-Fi terminals, smartphones, and smart-hardware products for international and local mobile data connectivity services. Geographically, it generates maximum revenue from Japan.